CARLA TULLY APPOINTED TO NIKOLA BOARD OF DIRECTORS
Energy expert joins Nikola's Board as 2024 infrastructure business expands PHOENIX, Feb. 16, 2024 /PRNewswire/ -- Nikola Corporation (Nasdaq: NKLA), a...
Month: February 2024
CARLA TULLY APPOINTED TO NIKOLA BOARD OF DIRECTORS
Energy expert joins Nikola's Board as 2024 infrastructure business expands PHOENIX, Feb. 16, 2024 /PRNewswire/ -- Nikola Corporation (Nasdaq: NKLA), a...
Marvell Technology, Inc. Updates Conference Call Timing to Review Fourth Fiscal Quarter and Fiscal Year 2024 Financial Results
SANTA CLARA, Calif., Feb. 16, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in infrastructure semiconductor solutions, today...
Marvell Technology, Inc. Updates Conference Call Timing to Review Fourth Fiscal Quarter and Fiscal Year 2024 Financial Results
SANTA CLARA, Calif., Feb. 16, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in infrastructure semiconductor solutions, today...
Lumentum Announces Upcoming Investor Events
Contacts Investors: Kathy Ta, 408-750-3853; investor.relations@lumentum.com Media: Noël Bilodeau, 408-439-2140; noel.bilodeau@lumentum.com or Hotwire Global, lumentum@hotwireglobal.com Lumentum Holdings Inc. ("Lumentum") today...
Lumentum Announces Upcoming Investor Events
Contacts Investors: Kathy Ta, 408-750-3853; investor.relations@lumentum.com Media: Noël Bilodeau, 408-439-2140; noel.bilodeau@lumentum.com or Hotwire Global, lumentum@hotwireglobal.com Lumentum Holdings Inc. ("Lumentum") today...
Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
Expansion Deepens Ligand’s Commercial, Clinical and Investment Expertise Contacts Investors: Tavo Espinoza investors@ligand.com (858) 550-7766 LifeSci Advisors Bob Yedid bob@lifesciadvisors.com...
Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
Expansion Deepens Ligand’s Commercial, Clinical and Investment Expertise Contacts Investors: Tavo Espinoza investors@ligand.com (858) 550-7766 LifeSci Advisors Bob Yedid bob@lifesciadvisors.com...
LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference
SALT LAKE CITY, Feb. 16, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products...
LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference
SALT LAKE CITY, Feb. 16, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products...
Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share
SAN FRANCISCO and SAN DIEGO, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate” or the “Company”),...
Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share
SAN FRANCISCO and SAN DIEGO, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate” or the “Company”),...
Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
EDISON, N.J., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on artificial...
Broadcom Inc. to Announce First Quarter Fiscal Year 2024 Financial Results on Thursday, March 7, 2024; Conference call at 2:15 p.m. Pacific Time
PALO ALTO, Calif., Feb. 16, 2024 /PRNewswire/ -- Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops and...
Broadcom Inc. to Announce First Quarter Fiscal Year 2024 Financial Results on Thursday, March 7, 2024; Conference call at 2:15 p.m. Pacific Time
PALO ALTO, Calif., Feb. 16, 2024 /PRNewswire/ -- Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops and...
Luckin Coffee to Announce Fourth Quarter and Full Year 2023 Financial Results on February 23, 2024
BEIJING, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) will release its...
Livento Group (NUGN) BOXO: Land of Bad Movie Release
NEW YORK, NY / ACCESSWIRE / February 16, 2024 / BOXO Productions, a trailblazer in the film production industry, proudly...
Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024
NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that...
Clayton Gits Brings Mission Realty and an Expansive Professional Network to Real
Contacts Investor inquiries: Ravi Jani Vice President, Investor Relations and Financial Planning & Analysis investors@therealbrokerage.com 908.280.2515 Media inquiries: Elisabeth Warrick...
Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation
MELBOURNE, Australia and NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a...
Sarepta Therapeutics Announces U.S. FDA Acceptance of an Efficacy Supplement to Expand the ELEVIDYS Indication
– Priority review granted, with a review goal date of June 21, 2024 Contacts Investor: Ian Estepan, 617-274-4052 iestepan@sarepta.com Media:...
SMX (Security Matters) PLC Announces Pricing of $2.9 Million Public Offering
NEW YORK, Feb. 16, 2024 /PRNewswire/ -- SMX (Security Matters) PLC (NASDAQ:SMX; SMXWW), today announced the pricing of a public offering...
MARINE PETROLEUM TRUST ANNOUNCES FIRST QUARTER CASH DISTRIBUTION
DALLAS, Feb. 16, 2024 /PRNewswire/ -- Marine Petroleum Trust (NASDAQ: MARPS) ("Marine") today declared a quarterly cash distribution to the...
Extreme Networks Announces Investor Conference Schedule for February and March 2024
Contacts Investor Relations Stan Kovler Vice President, Corporate Strategy & Investor Relations Extreme Networks 919-595-4196 skovler@extremenetworks.com Press Contact Amy Aylward...
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass., Feb. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing...
CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA
BEIJING, Feb. 16, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company specializing in the development and commercialization...
Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
MONTVALE, N.J., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2023 fiscal...
LiTHOS Supports Arkansas Lithium Innovation Summit and Stands Poised to Revolutionize Lithium Extraction at Scale
VANCOUVER, BC, Feb. 16, 2024 /PRNewswire/ - LiTHOS Group Ltd. ("LiTHOS" or the "Company") (CBOE CA: LITS) (OTCQB: LITSF) (FSE:...
Pharvaris Announces Extraordinary Meeting of Shareholders
ZUG, Switzerland , Feb. 16, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2...
KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
– Late-breaking phase 3 data for KONFIDENT trial on Sunday, February 25, 2024 – Contacts KalVista Pharmaceuticals, Inc. Jarrod Aldom...
Building Inclusive Spaces: Starbucks Announces New Accessibility Guidelines for its U.S. Store Portfolio
The company will leverage its growing store footprint to support access and inclusion for the partners, customers and communities it...
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
Contacts Media: Robbie Lunt robbie.lunt@biodesix.com 1-(866)-432-5930 Investors: Chris Brinzey chris.brinzey@westwicke.com (339) 970-2843 Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions...
Livento Group Enters into Equity Purchase Agreement to Pursue Strategic Expansion in Robotics and AI Division
NEW YORK, NY / ACCESSWIRE / February 16, 2024 / Livento Group, Inc. (OTC PINK:NUGN) a leading innovator in diversified...
Hydrogen Technologies to Present and Exhibit at IDEA Campus Energy 2024 Conference in San Francisco February 20 – 23
TULSA, OK and VANCOUVER, BC / ACCESSWIRE / February 16, 2024 / Hydrogen Technologies ("HT"), developer of the patented, pioneering...
MoneyHero Group Anticipates Year-Over-Year Revenue Growth of at Least 60% in Singapore and 50% in Hong Kong
SINGAPORE, Feb. 16, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a market-leading personal finance aggregation...
Fusion Fuel Receives Notification of IPCEI Approval from European Commission for 630 MW HEVO-Portugal Project
SABUGO, Portugal, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Fusion Fuel (NASDAQ: HTOO) (the “Company”) is pleased to announce that it...
Ericsson to utilize mandate to transfer shares
STOCKHOLM, Feb. 16, 2024 /PRNewswire/ -- Ericsson's (NASDAQ:ERIC) annual general meeting on March 29, 2023 authorized the company's board of...
Market Update – Infintium Copper Applies for Mining Permits and Receives Results of Metallurgical Test Work
VANCOUVER, BC / ACCESSWIRE / February 16, 2024 / Infinitum Copper Corp. (TSXV:INFI)(OTCQB:INUMF) ("Infinitum" or the "Company") is pleased to...
Toggle3D.ai Launches Suite of GPT AI 3D Solutions Led by Former Microsoft Executive, In Partnership with Nextech3D.ai
TORONTO, ON / ACCESSWIRE / February 16, 2024 / Toggle3D.ai (the "Company") (CSE:TGGL)(OTCQB:TGGLF)(FSE:Q0C), a revolutionary AI solution harnessing the power...
Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)
Approval based on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placeboCSU is the fifth approved...